Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Triple Negative Breast Neoplasms × Etoposide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Neoplasm Metastasis 1

Interventions

Epirubicin 4 Paclitaxel 3 Cyclophosphamide 3 Carboplatin 3 anlotinib 2 Capecitabine 2 pirarubicin 1 lobaplatin 1 eribulin 1 Zoledronic Acid 1 Granulocyte Colony-Stimulating Factor 1 Etoposide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04452370 2021-07-21

Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer

ChineseAMS

Phase 2 Unknown

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡